Peter Baird serves as a senior advisor to Vantage Capital on operating and strategic issues， including pre-transaction commercial diligence， and performance-improvement work with the portfolio companies.
Peter was formerly a partner at McKinsey & Company， serving a wide range of private equity and healthcare clients. In his ten years at McKinsey， the focus of his practise was transactional support （M&A， leveraged buyouts， in-licensing， joint ventures， and alliances） and corporate and business-unit strategy. In 2006， Peter was recruited by Blackstone to lead the $1.2 billion leveraged buyout of a medical-device manufacturer called ReAble Therapeutics. In 2007， in a second leveraged buyout， worth nearly $3 billion， Peter led the successful merger of ReAble with one of its major competitors， DJO， Incorporated.
Earlier in his career， Peter was a principal at Brait Capital Partners in Johannesburg， and an investment banker at Lehman Brothers in New York. Peter currently sits on the boards of two listed companies （EastPharma and Buildworks Group） and one privately held Blackstone portfolio company （Catalent Pharma Solutions）.
Peter holds an MBA from the Stanford Graduate School of Business， where he was an Arjay Miller Scholar. He also holds an MA （Economics） from the University of Cape Town， and a BA （Honours） in Economics and Political Theory from Bates College. Peter is a Chartered Financial Analyst.
